La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Antiparkinson Agents (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (1999) J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. MalbezinA randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000069 (1999) Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000091 (2000) T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E GrossEffects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000099 (????) [Parkinson disease].
000118 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000125 (2000) R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. SokoloffInvolvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
000162 (2001) B. Herer [France] ; I. Arnulf ; B. HoussetEffects of levodopa on pulmonary function in Parkinson's disease.
000198 (2001) N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. PoindronThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
000219 (2001) P. Krystkowiak [France] ; J L Blatt ; J L Bourriez ; A. Duhamel ; M. Perina ; G. Kemoun ; S. Blond ; J D Guieu ; A. Destée ; L. DefebvreChronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system.
000222 (2001) S. Thobois [France] ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
000224 (2002) Luc J P. Defebvre [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Alain Duhamel ; Jean-Louis Bourriez ; Myriame Périna ; Serge Blond ; Jean-Daniel Guieu ; Alain Destée [France]Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease.
000259 (2002) André Nieoullon [France]Dopamine and the regulation of cognition and attention.
000261 (????) Bernard Bruguerolle [France] ; Nicolas SimonBiologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.
000268 (2002) Anne-Marie Bonnet [France][Alpha-2 adrenergic receptors and Parkinson's disease].
000436 (2004) Vincent Paillé [France] ; Philippe Brachet ; Philippe DamierRole of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease.
000460 (2004) Jean-Christophe Corvol [France] ; Marie-Paule Muriel ; Emmanuel Valjent ; Jean Féger ; Naïma Hanoun ; Jean-Antoine Girault ; Etienne C. Hirsch ; Denis HervéPersistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.
000499 (2005) E. Bezard [France] ; C E Gross ; Li Qin ; V V Gurevich ; J L Benovic ; E V GurevichL-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain.
000553 (2005) Olivier Rascol [France]Rasagiline in the pharmacotherapy of Parkinson's disease--a review.
000571 (2006) D. Guehl [France] ; P. Dehail ; M P De Sèze ; E. Cuny ; P. Faux ; F. Tison ; M. Barat ; B. Bioulac ; P. BurbaudEvolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study.
000657 (2006) Mauricette Brocco [France] ; Anne Dekeyne ; Mariusz Papp ; Mark J. MillanAntidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
000788 (2008) Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette AkwaDisease-modifying drugs and Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024